Changes in graft function in long term renal transplant recipients – analysis by CKD stage and recipient characteristics U.P.Udayaraj, D.Ansell, R.Steenkamp,

Slides:



Advertisements
Similar presentations
Detection, monitoring and referral of chronic kidney disease
Advertisements

Assesment of renal function in case of near normal creatinine (<1
Social deprivation, ethnicity and access to kidney transplantation in England and Wales Udaya Udayaraj.
Blood pressure and mortality risk in peritoneal dialysis patients in England and Wales Udaya P.Udayaraj, R.Steenkamp, F.Caskey, D.Ansell, C.Tomson UK Renal.
Cardiovascular disease and vascular calcification in CKD
HEART TRANSPLANTATION Overall ISHLT 2008 J Heart Lung Transplant 2008;27:
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:
Chronic kidney disease
Chronic kidney disease
CKD ML/LH What are people hoping to cover from the session today?
Multicenter database of clinical course of CKD patients Internal Medicine Jang Hye Ryoun.
Management of Stage 3 Chronic Kidney Disease (CKD) in General Practice
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
WHAT’S NEW IN CHRONIC KIDNEY DISEASE Thomas G. Ferguson, MD State Lead, CKD 4/30/13.
Chronic Kidney Disease Manju Sood GPST3. What is CKD? Chronic renal failure is the progressive loss of nephrons resulting in permanent compromise of renal.
Mayrene Hernandez, DO Advanced ProMed Inc. Billing and Management Solutions Board Certified in Family Medicine Clinical Assistant Professor for NSU.
Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
CKD In Primary Care Dr Mohammed Javid.
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
Change in prevalence of Chronic Kidney Disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010.
Use of clinical laboratory databases to enable early identification of patients at highest risk of developing end- stage kidney disease Dr David Kennedy.
Chronic kidney disease Mr James Hollinshead Public Health Analyst East Midlands Public Health Observatory (EMPHO) UK Renal Registry 2011 Annual Audit Meeting.
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
Annual Informatics Meeting Changes to the Renal Registry Dataset Fiona Braddon Clinical Informatics Manager.
SHEFFIELD GUIDELINES: RENAL DISEASE IN DIABETES Dr Jenny Stephenson GP, Stannington Medical Centre
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
Advanced CKD Study Daniel Ford UKRR Annual Audit Meeting June 2009.
Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients
Improving the utility of comorbidity records Retha Steenkamp UK Renal Registry.
Section 5: Configuration of healthcare to manage CKD.
Expert Systems in Renal Disease Kent Renal ServiceUniversity of KentSalford Hospital Chris Farmer Bernhard Klebe Jean IrvingDonal O’Donoghue Paul StevensRoger.
UKRR Dataset v4.1 How does it fit with the UKRDC ACTIONS IN YOUR RENAL UNIT TO IMPLEMENT THE NEW DATASET UK RENAL REGISTRY 2015 INFORMATICS MEETING: DATA.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
RAPAMUNE ® TM 1 Randomization Variable Day* to Day 386 Randomization Variable Day* to Day 386 RAPA, C min, TN0.765 CsA, C min, TN0.201 Gender0.117 Increasing.
CHAPTER 13 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.
UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients
Survival after graft failure Dr Lynsey Webb Registrar UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
Prevalence and management of cardiovascular risks in renal transplant recipients Dr VS Aithal Consultant Nephrologist Swansea.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
CHAPTER 13 Renal Transplantation Goh Bak Leong Fan Kin Sing Rohan Malek Bin Dato’ Dr. Johan Rosnawati Yahya S. Prasad Menon Tan Si Yen Wong Hin Seng Source:
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
Impact of Recipient and Donor Non-immunological factors on the Outcome of Expanded Criteria Deceased Donors Kidney Transplantation Dr Hajar Al Hayyan.
Hot Topics Clinical Dr Sian Stanley. Why Hot topics? GPs love them. Recurring theme throughout GP training. Who decides what’s hot and what’s not? Clinically.
New kidney offering scheme … Lorna Marson Deputy Chair, Kidney Advisory Group Work in progress.
Nephrology Journal Club The SPRINT Trial Parker Gregg
Effect of Acute Kidney Injury on Chronic Kidney Disease Progression and Proteinuria: Initial Results from a Pilot Study Horne K1, Scott R1, Packington.
Mortality rates in incident ESRD patients figure 9
Number of transplants, by donor type figure 8.1
UK Renal Registry 16th Annual Report
Estimated GFR in Diabetes
T. Rana, L. Szabo, A. Asderakis, E. Ablorsu
Chronic Kidney Disease in HIV Infection: An Urban Epidemic
Renal Pharmacy Group Beginners Lectures 2018
UK Renal Registry 16th Annual Report
Introduction to Kidney Donor Risk Index (DRI)
UK Renal Registry 14th Annual Report
(A) Kaplan-Meier renal survival estimates of patients with diabetic nephropathy (DN), non-diabetic renal disease (NDRD) and mixed groups, adjusting for.
Risk factor Treatment GFR at baseline GFR at 5 years p Cadaveric donor
Arjang Djamali, Christina Kendziorski, Peter C. Brazy, Bryan N. Becker 
UK Renal Registry 10th Annual Report 2007
Demographic Characteristics of Cohort
Presentation transcript:

Changes in graft function in long term renal transplant recipients – analysis by CKD stage and recipient characteristics U.P.Udayaraj, D.Ansell, R.Steenkamp, R.Ravanan, C.Dudley UK Renal Registry

Introduction (1) All renal transplant recipients (RTR) have CKD CKD staging in RTR is based on eGFR only CKD stage 1T>90 ml/min/1.73m 2 CKD stage 2T60-89 ml/min/1.73m 2 CKD stage 3T30-59 ml/min/1.73m 2 CKD stage 4T15-29 ml/min/1.73m 2 CKD stage 5T<15 ml/min/1.73m 2 KDIGO Guidelines - Levey et al. KI 2005;67:

Introduction (2) Prevalence of various CKD stages and related complications in RTR have been reported CKD in RTR is not necessarily progressive – GFR was stable or improved in 50 % of patients But factors that predict rate of decline in GFR in RTR have not been studied adequately Ansell et al. Am J Transplant 2007;7 : Gill et al. J Am Soc Nephrol 2003;14: Stage1-2TStage3TStage4TStage5T 14%57%16%3%

Objectives To study the association between Recipient characteristics and severity of CKD Recipient characteristics and rate of decline in eGFR The rate of decline in eGFR and graft function

Methods (1) Patient Selection All prevalent RTR in UKRR database on were considered ( n= 13369) Those with ethnicity and creatinine data in last 2 quarters of 2004 were included (n=9542) eGFR was calculated using 4v MDRD equation Cross- sectional analysis of 9542 patients to examine severity of CKD by recipient characteristics

Methods (2) eGFR decline in following year was examined in 5553 patients who Had a functioning transplant for >1 year Survived the following year Had a eGFR 60) eGFR of 9 ml/min/1.73m 2 was imputed for graft loss

Methods (3) Recipient factors (predicting eGFR decline) that were investigated Graft function ( as in Dec 2004) Age Gender Ethnicity Primary (native) renal disease causing ERF Social deprivation UKRR does not collect data on proteinuria, acute rejection. Data on BP, BMI, smoking are incomplete.

Methods (4) Measurement of social deprivation Townsend score calculated from 2001 census output area % unemployed % households overcrowded % households with no car % households not owner occupied Patients postcode matched to output area Postcodes divided into quintiles – quintile 5 being more deprived Statistical analysis Chi squared test Kruskal Wallis test

Prevalence of CKD stages by recipient characteristics

Graft loss in following year by CKD stage

Recipient factors and 1 year change in eGFR

Recipient factors and 1 year change in GFR

Discussion (1) Graft loss increases with increasing CKD stage ~ 50 % of stage 5T lost their graft in the following year – need planning on access and transition onto dialysis /re transplantation Rate of decline in eGFR in RTR is much lower than reported in clinical trials in native renal diseases ( 4 ml/min/1.73m 2 /year) MDRD study – KI 1997;51:

Discussion (2) Progression of transplant CKD is increased in Younger age Non-whites Diabetics but independent of Gender Graft function Social deprivation Progression of native CKD is increased in Older age Non-whites Diabetics Males Poor baseline renal function Socially deprived patients Smokers Obesity Poorly controlled BP proteinuria

Discussion (3) Limitations Serum creatinine assay not standardised across UK and not aligned to MDRD lab Proteinuria and BP – 2 important modifiable risk factors not studied Insufficient immunosuppression data Future work To study association of donor factors, HLA mismatch, cold ischemic time ( UKT link) and GFR decline UKRR dataset expanded to include proteinuria Improve returns on BP, co-morbidity, BMI, ethnicity

Conclusions The rate of decline in eGFR in Transplant CKD is lower than that reported in clinical trials of native renal diseases is independent of graft function is increased in non- whites, diabetics - similar to that seen in native renal diseases is independent of gender, social deprivation and increased in younger age – in contrast to that seen in native renal diseases